Aardvark Therapeutics (AARD) Stock Chart & Stock Price History $11.60 -0.01 (-0.09%) As of 10:29 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Aardvark Therapeutics Stock Price Performance The Aardvark Therapeutics (AARD) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 6.91%, reflecting recent market activity. As of the latest close, Aardvark Therapeutics traded at $11.61 with a market cap of $251.89 million and volume of 40,020 shares. Receive AARD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.68%1 Month Performance+6.91%3 Month Performance+53.24% AARD Stock Chart for Wednesday, July, 16, 2025 AARD Chart by TradingView Aardvark Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$12.11$11.61-4.13%$12.20$11.2240,020 shs$251.89 million07/14/2025$12.17$12.11-0.49%$12.58$11.6560,803 shs$262.74 million07/11/2025$12.60$12.17-3.41%$12.65$12.1138,067 shs$264.04 million07/10/2025$12.73$12.60-1.02%$12.95$12.5122,884 shs$273.42 million07/09/2025$13.04$12.73-2.38%$13.21$12.5725,662 shs$276.24 million07/08/2025$13.92$13.04-6.32%$14.54$12.7049,370 shs$282.92 million07/07/2025$13.92$13.92$14.13$13.5051,870 shs$302.06 million07/04/2025$13.92$13.92$13.96$13.4410,562 shs$302.01 million07/03/2025$13.52$13.92+2.96%$13.96$13.4410,562 shs$302.06 million07/02/2025$13.56$13.52-0.29%$14.14$12.8241,789 shs$293.38 million Get the Latest News and Ratings for AARD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$13.52$13.56+0.30%$14.03$12.8667,627 shs$294.25 million06/30/2025$13.39$13.52+0.97%$14.12$13.4478,838 shs$293.38 million06/27/2025$13.86$13.39-3.39%$14.00$12.86676,046 shs$290.56 million06/26/2025$15.38$13.86-9.88%$15.43$13.5644,530 shs$300.76 million06/25/2025$15.76$15.38-2.41%$16.32$14.4846,831 shs$333.68 million06/24/2025$13.33$15.76+18.23%$15.87$12.51169,664 shs$341.99 million06/23/2025$11.13$13.33+19.77%$13.66$10.5487,791 shs$289.26 million06/20/2025$12.08$11.13-7.86%$12.09$10.6751,988 shs$241.48 million06/19/2025$12.08$12.08$12.18$11.03131,659 shs$262.14 million06/18/2025$11.27$12.08+7.19%$12.18$11.03131,659 shs$262.14 million06/17/2025$10.85$11.27+3.87%$11.32$10.2970,848 shs$244.51 million06/16/2025$10.74$10.85+1.02%$12.06$10.838,065 shs$235.40 million Related Companies GPCR Stock Price Chart COLL Stock Price Chart CDTX Stock Price Chart AKBA Stock Price Chart AMPH Stock Price Chart PRAX Stock Price Chart PHVS Stock Price Chart DYN Stock Price Chart BGM Stock Price Chart RCUS Stock Price Chart Receive AARD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AARD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aardvark Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aardvark Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
